Surge in Seizures of Illegal Dermal Fillers Sparks Health Warning from MHRA

Emily Watson, Health Editor
4 Min Read
⏱️ 3 min read

**

In a troubling development for cosmetic procedures, the Medicines and Healthcare products Regulatory Agency (MHRA) has confiscated illegal dermal fillers valued at a staggering £4 million. This warning comes as dermatologists raise alarms over the potential health risks associated with unlicensed fillers, which have been linked to serious complications including disfigurement and infections.

A Growing Concern

Since January 2020, the MHRA has seized over 27,000 units of unlicensed dermal fillers. The vast majority of these confiscations occurred in 2023, with a notable 19,754 units removed from circulation. In contrast, only 631 units were seized in 2025, indicating a concerning trend in the prevalence of these dangerous products.

While the MHRA has not disclosed the precise value of the seized fillers, experts estimate that they could range from £677,450 to an alarming £4 million, given that individual units typically retail between £25 and £150. The data, obtained by cosmetic clinic Vip Italia through a Freedom of Information request, highlights the urgent need for vigilance in the aesthetic industry.

The Risks of Unlicensed Fillers

Dermal fillers are widely used to address wrinkles and rejuvenate the skin. However, when sourced from unregulated suppliers, they pose significant health risks. Dr Emma Wedgeworth, a consultant dermatologist and spokesperson for the British Skin Foundation, warns that counterfeit fillers are not subject to crucial safety regulations, potentially leading to severe complications.

“The use of these fillers can result in disfigurement and infections, which may have severe health implications,” Dr Wedgeworth stated. Additionally, Dr Raoul Novelli, a plastic surgeon based in Milan, emphasised that inferior-quality fillers might contain harmful ingredients like preservatives and silicone, which can provoke unpredictable reactions, including severe allergies and permanent scarring.

Complications can also arise from the injection technique itself. If a filler is accidentally injected into or near a blood vessel, it can cause blocked arteries, leading to tissue necrosis and nerve damage. Other possible side effects include asymmetry, overfilling, and skin discolouration, underscoring the necessity for qualified practitioners.

How to Spot Counterfeit Fillers

Nora Nugent, a consultant plastic surgeon and president of the British Association of Aesthetic Plastic Surgeons (BAAPS), advises consumers to be cautious when considering dermal filler treatments. One major warning sign is pricing that seems unusually low compared to competitors, as unlicensed fillers are typically cheaper.

“Always be suspicious if a filler is being offered at a significantly reduced price or administered outside of a regulated healthcare environment,” Nugent cautioned. Furthermore, consumers should request information about batch numbers and expiry dates, as legitimate fillers will have this information clearly marked. Dr Novelli added that authentic fillers should appear clear and smooth, rather than cloudy or clumpy, and should come in robust syringes with clear branding.

The MHRA’s recent actions reflect a broader concern about illegal medicines; in 2025 alone, nearly 20 million doses of illegally traded medications were seized, with an estimated street value of £45 million. An MHRA spokesperson reiterated the risks associated with purchasing medicines from illegal online sources, emphasising the lack of safety assurances for such products.

Why it Matters

The alarming rise in the seizure of illegal dermal fillers not only highlights the risks posed to consumers but also underscores the urgent need for stricter regulations within the cosmetic industry. As aesthetic procedures become increasingly popular, it is crucial for individuals to be informed and cautious, ensuring that they choose licensed professionals and legitimate products. The health implications of counterfeit fillers can be severe, making it imperative for both consumers and practitioners to prioritise safety and quality over cost.

Share This Article
Emily Watson is an experienced health editor who has spent over a decade reporting on the NHS, public health policy, and medical breakthroughs. She led coverage of the COVID-19 pandemic and has developed deep expertise in healthcare systems and pharmaceutical regulation. Before joining The Update Desk, she was health correspondent for BBC News Online.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy